دورية
Weekly Versus Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
| العنوان: | Weekly Versus Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer |
|---|---|
| المؤلفون: | Chan, John K., Brady, Mark F., Penson, Richard T., Huang, Helen, Birrer, Michael J., Walker, Joan L., DiSilvestro, Paul A., Rubin, Stephen C., Martin, Lainie P., Davidson, Susan A., Huh, Warner K., O'Malley, David M., Boente, Matthew P., Michael, Helen, Monk, Bradley J. |
| المصدر: | Obstetrical and Gynecological Survey; June 2016, Vol. 71 Issue: 6 p344-345, 2p |
| مستخلص: | (Abstracted from N Engl J Med2016;374:738–748)The current standard treatment in first-line chemotherapy regimens for ovarian cancer (OC) is paclitaxel and carboplatin given every 3 weeks. It has been suggested that a dose-dense regimen of paclitaxel administered weekly (involving greater frequency of drug delivery) may enhance its antineoplastic effect. |
| قاعدة البيانات: | Supplemental Index |
| تدمد: | 00297828 15339866 |
|---|---|
| DOI: | 10.1097/OGX.0000000000000328 |